Dr. Carleton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Lakeville Road
New Hyde Park, NY 11042Phone+1 516-734-8966Fax+1 516-734-7687
Clinical Expertise
- Hematologic oncology
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1998- Tufts Medical CenterResidency, Internal Medicine, 1991 - 1994
University of Massachusetts Medical SchoolClass of 1991
Certifications & Licensure
NY State Medical License 2001 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2002 Nov 01
Publications & Presentations
PubMed
- 369 citationsPhase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124Primo N. Lara, Ronald B. Natale, John Crowley, Heinz-Josef Lenz, Mary W. Redman
Journal of Clinical Oncology. 2009-05-20 - 11 citationsFamily-building After Breast Cancer: Considering the Effect on Adherence to Adjuvant Endocrine TherapyCatherine Benedict, Bridgette Thom, Eleonora Teplinsky, Jane Carleton, Joanne Frankel Kelvin
Clinical Breast Cancer. 2017-06-01
Press Mentions
- Clinical Trials Saving Breast Cancer Patient Lives: A Long Island New York StoryOctober 28th, 2020
- Breast Cancer Clinical Trials at Long Island Hospitals Offering New HopeOctober 27th, 2020
Greater Treatment Options for Breast Cancer PatientsOctober 6th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
